- Trials with a EudraCT protocol (628)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
628 result(s) found for: Heart surgery.
Displaying page 4 of 32.
| EudraCT Number: 2008-003831-20 | Sponsor Protocol Number: 2008/27 | Start Date*: 2008-11-18 | |||||||||||
| Sponsor Name:Hopital Foch | |||||||||||||
| Full Title: Comparaison de l'effet de deux doses d'Acide Tranexamique sur les besoins transfusionnels en chirurgie cardiaque | |||||||||||||
| Medical condition: cardiac surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-018767-42 | Sponsor Protocol Number: CEUS-TEVAR-29 | Start Date*: 2011-05-06 | |||||||||||
| Sponsor Name:FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR | |||||||||||||
| Full Title: The use of Contrast Enhanced Transesophageal Echocardiography in thoracic endovascular aortic repair (TEVAR). Feasibility and safety of a new tool for intraoperative monitoring and follow up. | |||||||||||||
| Medical condition: descending thoracic aorta diseases | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-001086-32 | Sponsor Protocol Number: 19-001_AMG | Start Date*: 2020-01-02 |
| Sponsor Name:RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty | ||
| Full Title: ADVANCE-CSX Pilot – Antioxidant Treatment with Vitamin C in Cardiac Surgery Patients – a Clinical Pilot Study | ||
| Medical condition: Patients undergoing high-risk open-heart surgery with the use of cardiopulmonary bypass (CPB) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-004596-31 | Sponsor Protocol Number: NL62772 | Start Date*: 2019-03-25 | ||||||||||||||||
| Sponsor Name:UMC Utrecht | ||||||||||||||||||
| Full Title: CeRebrUm and CardIac protection with Allopurinol in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass | ||||||||||||||||||
| Medical condition: Brain injury in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Trial now transitioned) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2015-003995-65 | Sponsor Protocol Number: TAKICARD-1 | Start Date*: 2015-11-25 | |||||||||||
| Sponsor Name:Västra Götalandsregionen, Sahlgrenska University Hospital /Queen Silvia children's hospital | |||||||||||||
| Full Title: Pharmacokinetics of ANP, a diuretic hormone, in neonates undergoing surgery for congenital heart defects. A pilot study. | |||||||||||||
| Medical condition: Acute renal failure after heart surgery | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2011-004307-20 | Sponsor Protocol Number: | Start Date*: 2012-02-09 | ||||||||||||||||
| Sponsor Name:Reino Pöyhiä | ||||||||||||||||||
| Full Title: Comparison of periosteal and subcutaneous infusions of articaine and bupivacaine in treatment of acute pain after sternotomy | ||||||||||||||||||
| Medical condition: Patients undergoing elective open aortic or mitral valve, atrial septal defect or myxoma surgery | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FI (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2009-012372-27 | Sponsor Protocol Number: 200901 | Start Date*: 2009-09-17 | |||||||||||
| Sponsor Name:LUMC | |||||||||||||
| Full Title: The Sevoflurane study, understanding the effects of Sevoflurane to improve safety and outcome of cardiac surgery | |||||||||||||
| Medical condition: myocardial ischemia reperfusion injury during cardiac surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-000444-22 | Sponsor Protocol Number: NL75930.078.20 | Start Date*: 2021-04-07 |
| Sponsor Name:Erasmus MC | ||
| Full Title: Differences in coagulation between fresh frozen plasma and Solventdetergent plasma in pediatric congenital heart surgery | ||
| Medical condition: coagulation in pediatric cardiac surgery | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004672-35 | Sponsor Protocol Number: PACS2019 | Start Date*: 2020-01-10 |
| Sponsor Name:Institution for Clinical Science, Karolinska Institutet | ||
| Full Title: Open heart surgery – does it have to hurt that much? PACS – Parasternal After Cardiac Surgery. A prospective randomised study to assess the analgesic effect of a continuous bilateral parasternal bl... | ||
| Medical condition: The analgesic effect of continuous bilateral parasternal infusion of local anaesthetic after open cardiac surgery. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-003589-25 | Sponsor Protocol Number: Levo-AKI | Start Date*: 2014-11-11 |
| Sponsor Name:Sahlgrenska Universitetssjukhuset/Sahlgrenska | ||
| Full Title: The effect of levosimendan, on renal blood flow, function and oxygen uptake during acute renal failure after cardiac surgery | ||
| Medical condition: Acute kidney injury postoperatively in connection with heart surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-012624-93 | Sponsor Protocol Number: BREVI | Start Date*: 2009-06-08 | |||||||||||
| Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
| Full Title: Esmolol in cardiac surgery. A randomized controlled trial with clinical relevant endpoints. | |||||||||||||
| Medical condition: patients undergoing cardiac surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-003695-36 | Sponsor Protocol Number: | Start Date*: 2012-09-07 | |||||||||||
| Sponsor Name:Brighton & Sussex University Hospitals NHS Trust | |||||||||||||
| Full Title: Is intravenous iron and darbepoetin more effective than oral iron in reducing blood transfusion requirements for patients undergoing cardiac surgery | |||||||||||||
| Medical condition: Anaemia | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-002427-28 | Sponsor Protocol Number: CIT-003-01 | Start Date*: 2018-10-24 |
| Sponsor Name:Asklepion Pharmaceuticals, LLC | ||
| Full Title: A Phase III Double-Blind, Randomized, Placebo Controlled, Multi-Center Clinical Study to Evaluate the Efficacy and Safety of Intravenous L-citrulline for the Prevention of Clinical Sequelae of Acut... | ||
| Medical condition: Post-operative pulmonary dysfunction induced by cardiopulmonary bypass in pediatric subjects undergoing surgery for congenital heart defects. | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-004051-35 | Sponsor Protocol Number: INSTEM_HHU_2005 | Start Date*: 2006-09-01 | |||||||||||
| Sponsor Name:University Hospital Düsseldorf | |||||||||||||
| Full Title: Intramyocardial Application of Stem Cells in combination with transmyocardial Laser Revascularisation (TMLR) in CABG Patients | |||||||||||||
| Medical condition: Other forms of chronic ischaemic heart disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-017752-28 | Sponsor Protocol Number: MSCII | Start Date*: 2010-03-22 | |||||||||||
| Sponsor Name:Cardiovascular laboratory 2014, The Heart Centre, Rigshospitalet [...] | |||||||||||||
| Full Title: Stamcellebehandling af patienter med kronisk kranspulsåresygdom MesenchYmal STROMAL CELL therapy in patients with chronic myocardial ischemia (MyStromalCell Trial) | |||||||||||||
| Medical condition: Patients with severe stable coronary artery disease on medical therapy and no further revascularisation options with balloon angioplasty or coronary artery by-pass surgery and still severe angina p... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-007174-35 | Sponsor Protocol Number: AM-KS-IV/5/07 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||
| Full Title: Randomized, placebo-controlled phase-IV clinical trial for the application of physostigmine salicylate for an early post-operative restoration of vigilance and cognition after cardiopulmonary bypas... | |||||||||||||
| Medical condition: post-operative restoration of vigilance and cognition after cardiopulmonary bypass surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-002494-19 | Sponsor Protocol Number: NL61864.041.17 | Start Date*: 2017-12-21 |
| Sponsor Name:UMC Utrecht | ||
| Full Title: Dexamethasone for Cardiac Surgery trial: a novel 'Standard Practice Preference-Randomised Consent' Design. A PILOT STUDY | ||
| Medical condition: Inflammatory response to cardiac surgery | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-003046-13 | Sponsor Protocol Number: 2021/ABM/03/00008 | Start Date*: 2023-11-27 | |||||||||||
| Sponsor Name:Śląskie Centrum Chorób Serca | |||||||||||||
| Full Title: Sacubitril/Valsartan in PriMAry preventIoN of the cardiotoxicity of systematic breaST canceR trEAtMent. Randomized, multicenter, double-blind, placebo-controlled study. | |||||||||||||
| Medical condition: Heart failure – post-anthracycline cardiomyopathy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: PL (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-001027-33 | Sponsor Protocol Number: PAFIBAR1.0 | Start Date*: 2023-06-07 | |||||||||||
| Sponsor Name:FIMABIS | |||||||||||||
| Full Title: Evaluation of the effect of Opioid-Free Anesthesia on oxygenation in bariatric surgery | |||||||||||||
| Medical condition: Bariatric surgery | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-000191-41 | Sponsor Protocol Number: GC28210 | Start Date*: 2012-06-19 | |||||||||||
| Sponsor Name:GENENTECH, Inc. | |||||||||||||
| Full Title: A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF THE SAFETY AND EFFICACY OF MPSK3169A IN PATIENTS WITH CORONARY HEART DISEASE OR HIGH RISK OF CORONARY HEART DISEASE | |||||||||||||
| Medical condition: Coronary Heart Disease or High Risk of Coronary Heart Disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) DE (Completed) CZ (Completed) SK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.